Corpus 1,280 assessed · 1,181 scored · 646 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 5.1k

Explore

Filters: low ✕ Medicine ✕ rna-seq ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. PMID 39572705	Commun Biol	2024	68	L1 68/100

IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses.

PMID 40128415 · Breast Cancer · 2025

L1 71/100

Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer.

PMID 39572705 · Commun Biol · 2024

L1 68/100